Valion Bio names CFO Lisa Wolf president, COO after CEO Handley exits
VBIO•Board additions
The board added Jared Malbin, COO of Lucid Capital Markets, with broker-dealer operations, compliance, finance and capital-markets experience.
Thomas Jensen joined as director; he is CEO, co-founder and director of Allarity Therapeutics with biotech and oncology leadership experience.
Leadership change at Valion Bio
Valion Bio appointed CFO Lisa Wolf as president and COO, taking executive leadership following former CEO Michael K. Handley’s departure.
